These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6140806)

  • 21. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal and tolbutamide-induced plasma somatostatin in healthy subjects and in patients with diabetes and impaired glucose tolerance.
    Segers O; De Vroede M; Michotte Y; Somers G
    Diabet Med; 1989 Apr; 6(3):232-8. PubMed ID: 2565779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extraction of somatostatin from human plasma on octadecylsilyl silica.
    Vasquez B; Harris V; Unger RH
    J Clin Endocrinol Metab; 1982 Oct; 55(4):807-9. PubMed ID: 6125526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of somatostatin in peripheral and portal plasma in the duck: in-vivo metabolism of somatostatin-28 and -14.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    J Endocrinol; 1984 Mar; 100(3):329-35. PubMed ID: 6142074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma somatostatin response in normal and gastrectomized subjects.
    Wasada T; Kodama Y; Inoue K; Hisatomi A; Sako Y; Ibayashi H
    Tohoku J Exp Med; 1986 Oct; 150(2):181-8. PubMed ID: 2880412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian variations of plasma somatostatin levels in healthy subjects.
    Strazzulla G; Guazzelli R; Romano S; Matassi L; Cotrozzi G; Brocchi A
    Chronobiologia; 1990; 17(3):219-25. PubMed ID: 1977563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Processing of synthetic somatostatin-28 and a related endogenous rat hypothalamic somatostatin-like molecule by hypothalamic enzymes.
    Zingg HH; Patel YC
    Life Sci; 1982 Feb; 30(6):525-33. PubMed ID: 6122155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose infusion of somatostatin in man--no effect upon intestinal calcium absorption but a fall in blood insulin.
    Rümenapf G; Hanisch E; Schwille PO
    Exp Clin Endocrinol; 1986 Aug; 87(3):306-12. PubMed ID: 2877894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of guar intake on plasma somatostatin-like immunoreactivity in diabetic patients.
    Shimoyama R; Uehara S; Itagaki Y; Izumiyama S; Hirayama A
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):727-33. PubMed ID: 6134660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma glucagon and glucagon-like immunoreactive components in Type 1 (insulin-dependent) diabetic patients and normal subjects before and after an oral glucose load.
    Rovira A; Garrote FJ; Pascual JM; Salvador MG; Herrera Pombo JL; Valverde I
    Diabetologia; 1985 Feb; 28(2):80-6. PubMed ID: 3838521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential alterations of the circulating prosomatostatin-derived peptides during insulin-induced hypoglycemia in man.
    Francis BH; Ensinck JW
    J Clin Endocrinol Metab; 1987 Nov; 65(5):880-4. PubMed ID: 2889750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a role of free fatty acids in the regulation of somatostatin secretion in normal and alloxan diabetic dogs.
    Wasada T; Howard B; Dobbs RE; Unger RH
    J Clin Invest; 1980 Sep; 66(3):511-6. PubMed ID: 6105166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating forms of somatostatinlike immunoreactivity in human plasma.
    Shoelson SE; Polonsky KS; Nakabayashi T; Jaspan JB; Tager HS
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E428-34. PubMed ID: 3963183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.